Wealthcare Advisory Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.05M Buy
18,527
+352
+2% +$39K 0.05% 321
2025
Q1
$2.04M Sell
18,175
-88
-0.5% -$9.86K 0.05% 280
2024
Q4
$1.69M Buy
18,263
+2,229
+14% +$206K 0.05% 308
2024
Q3
$1.34M Buy
16,034
+1,445
+10% +$121K 0.04% 347
2024
Q2
$1M Buy
14,589
+913
+7% +$62.6K 0.03% 382
2024
Q1
$1M Sell
13,676
-419
-3% -$30.7K 0.03% 363
2023
Q4
$1.14M Buy
14,095
+477
+4% +$38.6K 0.05% 286
2023
Q3
$1.02M Sell
13,618
-984
-7% -$73.7K 0.05% 271
2023
Q2
$1.13M Sell
14,602
-203
-1% -$15.6K 0.05% 263
2023
Q1
$1.23M Sell
14,805
-933
-6% -$77.4K 0.05% 260
2022
Q4
$1.35M Buy
15,738
+3,404
+28% +$292K 0.06% 226
2022
Q3
$761K Buy
12,334
+470
+4% +$29K 0.04% 274
2022
Q2
$733K Buy
+11,864
New +$733K 0.04% 251
2022
Q1
Sell
-3,070
Closed -$223K 560
2021
Q4
$223K Sell
3,070
-5,391
-64% -$392K 0.01% 518
2021
Q3
$591K Buy
8,461
+218
+3% +$15.2K 0.04% 288
2021
Q2
$568K Sell
8,243
-2,024
-20% -$139K 0.04% 295
2021
Q1
$664K Buy
10,267
+5,497
+115% +$356K 0.05% 241
2020
Q4
$278K Buy
4,770
+727
+18% +$42.4K 0.02% 333
2020
Q3
$255K Buy
+4,043
New +$255K 0.03% 293
2020
Q2
Sell
-2,205
Closed -$165K 743
2020
Q1
$165K Sell
2,205
-1,266
-36% -$94.7K 0.02% 292
2019
Q4
$226K Buy
3,471
+1,282
+59% +$83.5K 0.03% 278
2019
Q3
$139K Sell
2,189
-61
-3% -$3.87K 0.02% 325
2019
Q2
$152K Buy
2,250
+87
+4% +$5.88K 0.02% 310
2019
Q1
$141K Buy
2,163
+4
+0.2% +$261 0.02% 283
2018
Q4
$135K Sell
2,159
-63
-3% -$3.94K 0.03% 268
2018
Q3
$172K Sell
2,222
-208
-9% -$16.1K 0.03% 245
2018
Q2
$172K Sell
2,430
-247
-9% -$17.5K 0.03% 236
2018
Q1
$202K Sell
2,677
-246
-8% -$18.6K 0.05% 193
2017
Q4
$209K Buy
2,923
+1,284
+78% +$91.8K 0.05% 171
2017
Q3
$133K Buy
+1,639
New +$133K 0.04% 184